Regenerative Medicine
-
As a technology, bioprinting seeks to revolutionize medical research and healthcare, paving the way for more holistic, patient-driven solutions. At the same time, it is important to remember that bioprinting is just a tool, and what is truly innovative about it are the applications and uses being developed for it…
Read More -
Fluicell, a Sweden-based bioprinting startup founded in 2012 as a spin-out of the Chalmers University of Technology, has undertaken research to develop medicinal products for treating type 1 diabetes. The project, which recently achieved a significant milestone, is based on biocomposite tissues generated by Fluicell’s Biopixlar system. As of today,…
Read More -
The investment into Nottingham-based 4D Biomaterials was led by DSW Ventures and backed by the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and part of the Midlands Engine Investment Fund, Mercia’s own funds, and existing investor SFC Capital. The funding will be used to…
Read More -
restor3d merged with Kinos Medical, an expert total ankle replacement company. restor3d was founded with a mission to enable surgeons to repair and reconstruct the human body using 3D printing technologies, advanced biomaterials, and artificial intelligence. In 2018, the company invested in significant infrastructure and in-house manufacturing capabilities to expand…
Read More -
Dimension Inx, a regenerative biomaterials company, has been awarded funding from the United States Department of Defense to develop innovative products to repair tracheal injuries. The $240,000 award will support the initial development of a new tracheal implant solution that overcomes current limitations and can be readily applied for emergency…
Read More -
Population aging is one of Europe’s great challenges in the 21st century. By 2024, 22% of Europeans are expected to be over 65. Patients suffering from chronic joint detop fects or defects in the oral and maxillofacial regions have a significantly reduced quality of life and are continually dependent on…
Read More -
CollPlant Biotechnologies released a letter from its Chief Executive Officer, Yehiel Tal, to its shareholders. The letter summarizes a strong year for the company and its shareholders, which has benefitted from the uptick in 3D printing research and interest throughout 2020 to position itself for an even stronger 2021. The letter…
Read More -
3D Systems significantly expanded its focus on regenerative medicine and bioprinting solutions after reducing its workforce to concentrate on the healthcare AM sector. The expanded focus follows on great progress made in the development of 3D printing systems for solid-organ scaffolds. This progress is the product of collaboration between 3D…
Read More -
Advanced Development of Additive Manufacturing (A.D.A.M.) is on the cusp of releasing 3D printed bioresorbable bone implants. The implants would, if successful, be completely absorbed by the body. Recovery times would improve; patients would undergo fewer surgeries; the implant is personalized to each patient. The application for this technology needs…
Read More -
3D Bioprinting Solutions and the P. A. Hertsen Moscow Oncology Research Center conducted a unique experiment on implant in-situ bioprinting to replace skin defects. The experiment was carried out in-situ – that is, “on the spot” – on live rats during an operation in the laboratory of preclinical studies of…
Read More
